Koen De WinnePhilippe BüscherAlejandro O. LuquettiSuelene B. N. TavaresRodrigo Arruda de OliveiraAldo SolariInés ZulantayWerner AptPatricio DiosqueMercedes Rumi2026-03-222026-03-22201410.1371/journal.pntd.0002633https://doi.org/10.1371/journal.pntd.0002633https://andeanlibrary.org/handle/123456789/47470Citaciones: 18Specificities of the two T. cruzi OligoC-TesT prototypes are high on non-endemic and endemic controls. Sensitivities are moderate but significantly (p = 0.0004) higher for the kDNA OligoC-TesT compared to the satDNA OligoC-TesT.enChagas diseaseKinetoplastTrypanosoma cruziMedicineBiologyVirologyImmunologyInternal medicinearticle